334 related articles for article (PubMed ID: 15883640)
41. Folliculogenesis is impaired and granulosa cell apoptosis is increased in leptin-deficient mice.
Hamm ML; Bhat GK; Thompson WE; Mann DR
Biol Reprod; 2004 Jul; 71(1):66-72. PubMed ID: 14985253
[TBL] [Abstract][Full Text] [Related]
42. [Effects of glucose and insulin in the cell differentiation from bone marrow stem cells to osteoblasts].
Li YM; Deng B; Li LH; Deng LP; Gao HB; Chen LL
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(36):2583-5. PubMed ID: 20137625
[TBL] [Abstract][Full Text] [Related]
43. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).
Sottile V; Seuwen K; Kneissel M
Calcif Tissue Int; 2004 Oct; 75(4):329-37. PubMed ID: 15549648
[TBL] [Abstract][Full Text] [Related]
44. TNFalpha induces and insulin inhibits caspase 3-dependent adipocyte apoptosis.
Qian H; Hausman DB; Compton MM; Martin RJ; Della-Fera MA; Hartzell DL; Baile CA
Biochem Biophys Res Commun; 2001 Jun; 284(5):1176-83. PubMed ID: 11414707
[TBL] [Abstract][Full Text] [Related]
45. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats.
Trivedi R; Kumar S; Kumar A; Siddiqui JA; Swarnkar G; Gupta V; Kendurker A; Dwivedi AK; Romero JR; Chattopadhyay N
Mol Cell Endocrinol; 2008 Jul; 289(1-2):85-93. PubMed ID: 18400372
[TBL] [Abstract][Full Text] [Related]
46. Unloading-induced bone loss was suppressed in gold-thioglucose treated mice.
Hino K; Nifuji A; Morinobu M; Tsuji K; Ezura Y; Nakashima K; Yamamoto H; Noda M
J Cell Biochem; 2006 Oct; 99(3):845-52. PubMed ID: 16721830
[TBL] [Abstract][Full Text] [Related]
47. Defective leptin-AMP-dependent kinase pathway induces nitric oxide release and contributes to mitochondrial dysfunction and obesity in ob/ob mice.
Finocchietto PV; Holod S; Barreyro F; Peralta JG; Alippe Y; Giovambattista A; Carreras MC; Poderoso JJ
Antioxid Redox Signal; 2011 Nov; 15(9):2395-406. PubMed ID: 21529143
[TBL] [Abstract][Full Text] [Related]
48. Impaired marrow osteogenesis is associated with reduced endocortical bone formation but does not impair periosteal bone formation in long bones of SAMP6 mice.
Silva MJ; Brodt MD; Ko M; Abu-Amer Y
J Bone Miner Res; 2005 Mar; 20(3):419-27. PubMed ID: 15746986
[TBL] [Abstract][Full Text] [Related]
49. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals.
Li Y; He X; Li Y; He J; Anderstam B; Andersson G; Lindgren U
J Bone Miner Res; 2011 Nov; 26(11):2656-64. PubMed ID: 21812028
[TBL] [Abstract][Full Text] [Related]
50. Impaired energetic metabolism after central leptin signaling leads to massive appendicular bone loss in hindlimb-suspended rats.
Martin A; David V; Vico L; Thomas T
J Bone Miner Res; 2008 Dec; 23(12):2040-7. PubMed ID: 18665796
[TBL] [Abstract][Full Text] [Related]
51. Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway.
Martin A; David V; Malaval L; Lafage-Proust MH; Vico L; Thomas T
Endocrinology; 2007 Jul; 148(7):3419-25. PubMed ID: 17431002
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Georgiou KR; Scherer MA; Fan CM; Cool JC; King TJ; Foster BK; Xian CJ
J Cell Physiol; 2012 Mar; 227(3):909-18. PubMed ID: 21503894
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of transthyretin in leptin-deficient ob/ob mice is not causative for their major phenotypic abnormalities.
Rendenbach C; Ganswindt S; Seitz S; Barvencik F; Huebner AK; Baranowsky A; Streichert T; Niemeier A; Heeren J; Amling M; Bartelt A; Schinke T
J Neuroendocrinol; 2013 Jan; 25(1):14-22. PubMed ID: 22849972
[TBL] [Abstract][Full Text] [Related]
54. Prevention of fasting-mediated bone marrow atrophy by leptin administration.
Fujita Y; Yanagida H; Mimori T; Jin ZX; Sakai T; Kawanami T; Sawaki T; Masaki Y; Fukushima T; Okazaki T; Umehara H
Cell Immunol; 2012; 273(1):52-8. PubMed ID: 22196379
[TBL] [Abstract][Full Text] [Related]
55. Substantiation of ovarian effects of leptin by challenging a mouse model of obesity/type 2 diabetes.
Pallares P; Garcia-Fernandez RA; Criado LM; Letelier CA; Fernandez-Toro JM; Esteban D; Flores JM; Gonzalez-Bulnes A
Theriogenology; 2010 May; 73(8):1088-95. PubMed ID: 20172601
[TBL] [Abstract][Full Text] [Related]
56. Effect of reduced c-Kit signaling on bone marrow adiposity.
Turner RT; Wong CP; Iwaniec UT
Anat Rec (Hoboken); 2011 Jul; 294(7):1126-34. PubMed ID: 21634019
[TBL] [Abstract][Full Text] [Related]
57. Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism.
Philbrick KA; Wong CP; Branscum AJ; Turner RT; Iwaniec UT
J Endocrinol; 2017 Mar; 232(3):461-474. PubMed ID: 28057869
[TBL] [Abstract][Full Text] [Related]
58. High-dose estrogen induces de novo medullary bone formation in female mice.
Samuels A; Perry MJ; Tobias JH
J Bone Miner Res; 1999 Feb; 14(2):178-86. PubMed ID: 9933470
[TBL] [Abstract][Full Text] [Related]
59. Leptin and insulin modulate nutrient partitioning and weight loss in ob/ob mice through regulation of long-chain fatty acid uptake by adipocytes.
Fan X; Bradbury MW; Berk PD
J Nutr; 2003 Sep; 133(9):2707-15. PubMed ID: 12949354
[TBL] [Abstract][Full Text] [Related]
60. Role of estrogen receptor signaling in skeletal response to leptin in female
Turner RT; Philbrick KA; Kuah AF; Branscum AJ; Iwaniec UT
J Endocrinol; 2017 Jun; 233(3):357-367. PubMed ID: 28428364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
